Interview with Professor, Dr. Geert Jan Groeneveld about myasthenia gravis
It all begins with an idea.
NMD Pharma Doses the First Myasthenia Gravis Patient in a Combined Phase I/IIa Clinical Trial of NMD670
It all begins with an idea.
It all begins with an idea.
It all begins with an idea.